Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients
Clinical trial NCT00046371 · COMPLETED
Trial details
- NCT number
- NCT00046371
- Sponsor
- Oncothyreon Canada Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.